Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases.
about
Deletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine candidate NYVAC-CAvipoxviruses: infection biology and their use as vaccine vectorsImproved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectorsPreparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells.Naturally occurring orthopoxviruses: potential for recombination with vaccine vectors.Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIVALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiencyMyxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins.Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.Applications of pox virus vectors to vaccination: an update.The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in miceVirological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infectionRole of cell signaling in poxvirus-mediated foreign gene expression in mammalian cellsVaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in miceSafety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial.Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.Vaccinia virus vaccines: past, present and future.The canarypox virus vector ALVAC induces distinct cytokine responses compared to the vaccinia virus-based vectors MVA and NYVAC in rhesus monkeys.OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory virusesTwo-helper RNA system for production of recombinant Semliki forest virus particles.Identification and characterization of three immunodominant structural proteins of fowlpox virus.
P2860
Q27306437-6A3CFFEB-8692-4A88-8D97-ED55F5939D51Q28304570-C505D303-C1D4-4268-A1FD-DEB83D81FAC1Q28742751-19050EB1-7311-49D5-A86B-C3B71530F459Q30377222-D4ABD1F0-D496-47C5-A886-F3ACDFBDDCDFQ33682107-30AA2E0B-0AF5-4E48-BDFB-09EBF990FF3DQ33782797-BBCDD1EE-1A5A-47CC-B8C3-04C1BA57AC5FQ33800033-164366A8-1C82-408C-B8E7-1DD2EFD8D79AQ34326613-0EECD7AC-B96B-4C40-AA55-7685D3E17073Q34332353-3F59A29B-5ECE-4DBE-8245-F0E5A2272A24Q34355037-63B6E1FF-348B-4D90-B1D5-A64CD8299B9CQ34403246-49C74624-1872-47C4-A129-F49678DD0B1CQ34428899-558813E5-663C-46DA-80C2-A5AC7EF009CAQ34991112-F25D432A-EB5E-49C7-B43C-3B5266FCD8A0Q35193006-9FBCE65C-F23D-49A9-B286-BAA34F4A0777Q35292450-4EDE5AD0-4AA3-4738-A5A1-FE0BAA722AD3Q35571248-F3132D27-BEE0-43B8-AF24-92CB3C7ECA16Q35943846-393EB4BA-7801-48BF-B461-A20201EED3C3Q36846282-7BCAE4B1-173F-4805-BFC5-66AFC3452C1AQ36911682-5437723B-5677-411F-B5CD-D3D352AA0CD5Q37343595-E0189BAC-8090-4659-BA38-D42D0E2CB076Q37547241-38834B22-331D-43A5-9BE6-0E5527C3A93EQ37948126-EEC6BAA0-9C23-40D1-B76D-D58B82EF28BDQ39549251-26D526E8-9323-46F4-87B7-1C51F3D877E2Q39684877-534E93CF-DCFD-4C3F-A6C6-3F68C6E12B45
P2860
Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases.
@en
type
label
Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases.
@en
prefLabel
Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases.
@en
P2093
P356
P1476
Poxvirus-based vaccine candidates for cancer, AIDS, and other infectious diseases
@en
P2093
E Paoletti
J Tartaglia
M E Perkus
P356
10.1002/JLB.58.1.1
P577
1995-07-01T00:00:00Z